ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer.

Wei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.